Aplicación YC de Rhizome AI

Winter 2026Active

Rhizome AI pasó por Y Combinator en el batch Winter 2026 como una empresa de B2B. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.

Batch YC: Winter 2026
Industria: B2B
Tamaño del equipo: 1
Estado: Active
Lanzado: 2026

Fundadores

Chetan MishraFounder

Lo que hace Rhizome AI

It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.

Aplicación YC de Rhizome AI, reconstruida

Solicitud de Y Combinator

Rhizome AI, batch Winter 2026. Las preguntas reales del formulario, respondidas con datos públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rhizome AI

Describe what your company does in 50 characters or less.

Agent Platform for Life Sciences

What is your company going to make? Please describe your product and what it does or will do.

We built a research agent that helps regulatory professionals understand FDA guidance by answering their questions with citations from up to 1,000 relevant documents. It's powered by a retrieval engine tuned specifically on life science datasets that finds regulatory information others miss. Our product aims to automate much of the work involved in navigating drug approval processes.

Where do you live now, and where would the company be based after YC?

I live in New York City and the company is based there and remotely distributed.

Explain your decision regarding location.

New York is a major life sciences hub, and remote lets us access talent and customers globally. This fits our need to stay close to regulatory experts and life sciences teams while keeping flexibility.

21 respuestas más en la aplicación completa

están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.

Ver aplicación completa

Preguntas Frecuentes

¿Es esta la aplicación YC real de Rhizome AI?

No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Rhizome AI (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Rhizome AI se presentaría a YC, no el texto que enviaron.

¿En qué batch de YC estuvo Rhizome AI?

Rhizome AI formó parte del batch Winter 2026 de Y Combinator.

¿Quién fundó Rhizome AI?

Rhizome AI fue fundado por Chetan Mishra.

¿A qué se dedica Rhizome AI?

Agent Platform for Life Sciences

¿Cómo leo la aplicación completa reconstruida?

Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Rhizome AI, y de cada otro batch de YC, está en YC Insights.